Jinming Liu

2.9k total citations
146 papers, 1.8k citations indexed

About

Jinming Liu is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Jinming Liu has authored 146 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Pulmonary and Respiratory Medicine, 38 papers in Cardiology and Cardiovascular Medicine and 27 papers in Molecular Biology. Recurrent topics in Jinming Liu's work include Pulmonary Hypertension Research and Treatments (61 papers), Cardiovascular Function and Risk Factors (22 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (21 papers). Jinming Liu is often cited by papers focused on Pulmonary Hypertension Research and Treatments (61 papers), Cardiovascular Function and Risk Factors (22 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (21 papers). Jinming Liu collaborates with scholars based in China, United States and Canada. Jinming Liu's co-authors include Bigyan Pudasaini, James H. Schwartz, Lan Wang, Su‐Gang Gong, Ping Yuan, Qin‐Hua Zhao, Rong Jiang, Frederica P. Perera, Lung‐Chi Chen and Rachel L. Miller and has published in prestigious journals such as Circulation, Nature Communications and Journal of Neuroscience.

In The Last Decade

Jinming Liu

135 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinming Liu China 23 651 492 301 287 232 146 1.8k
Alison Campbell France 26 742 1.1× 349 0.7× 170 0.6× 51 0.2× 103 0.4× 74 2.4k
Clarence E. Chrisp United States 28 223 0.3× 684 1.4× 254 0.8× 60 0.2× 45 0.2× 72 2.7k
José Manuel Rodrı́guez-Pérez Mexico 26 82 0.1× 410 0.8× 131 0.4× 237 0.8× 88 0.4× 114 1.9k
Ono K Japan 24 152 0.2× 988 2.0× 178 0.6× 827 2.9× 26 0.1× 178 2.2k
Amanda Fisher United States 24 812 1.2× 326 0.7× 34 0.1× 321 1.1× 23 0.1× 50 1.8k
K. Herkner Austria 32 481 0.7× 582 1.2× 126 0.4× 113 0.4× 13 0.1× 98 2.7k
Frank Stassen Netherlands 32 387 0.6× 1.3k 2.7× 35 0.1× 406 1.4× 40 0.2× 79 3.0k
Rafael Bojalil Mexico 25 85 0.1× 261 0.5× 570 1.9× 163 0.6× 153 0.7× 70 2.1k
Andrew J. Lechner United States 27 537 0.8× 430 0.9× 22 0.1× 69 0.2× 160 0.7× 80 1.9k
Galileo Escobedo Mexico 21 49 0.1× 301 0.6× 274 0.9× 107 0.4× 148 0.6× 101 1.6k

Countries citing papers authored by Jinming Liu

Since Specialization
Citations

This map shows the geographic impact of Jinming Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinming Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinming Liu more than expected).

Fields of papers citing papers by Jinming Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinming Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinming Liu. The network helps show where Jinming Liu may publish in the future.

Co-authorship network of co-authors of Jinming Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jinming Liu. A scholar is included among the top collaborators of Jinming Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinming Liu. Jinming Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Qin‐Hua, Rui Zhang, Shao‐Fei Liu, et al.. (2025). Phenotypic Analysis of Pulmonary Hypertension Associated With Low Diffusion Capacity and Preserved Lung Function. Pulmonary Circulation. 15(4). e70210–e70210.
2.
3.
4.
5.
Zhou, Guangyuan, Yunpeng Wei, Ting Zhang, et al.. (2024). Identification of Noncoding Functional Regulatory Variants of STIM1 Gene in Idiopathic Pulmonary Arterial Hypertension. Hypertension. 81(9). 1895–1909. 1 indexed citations
6.
Hu, Xiaoyi, Yuanyuan Sun, Shang Wang, et al.. (2024). CircALMS1 Alleviates Pulmonary Microvascular Endothelial Cell Dysfunction in Pulmonary Hypertension. Journal of the American Heart Association. 13(6). e031867–e031867. 3 indexed citations
7.
Shen, Qunshan, Qin‐Hua Zhao, Huiting Li, et al.. (2024). Improvements in Hemodynamics and Right Heart Remodeling Following Balloon Pulmonary Angioplasty Treatment in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Study. Health Science Reports. 7(11). e70159–e70159. 1 indexed citations
8.
Hu, Xiaoyi, Shang Wang, Hui Zhao, et al.. (2023). CircPMS1 promotes proliferation of pulmonary artery smooth muscle cells, pulmonary microvascular endothelial cells, and pericytes under hypoxia. SHILAP Revista de lepidopterología. 7(3). 310–323. 4 indexed citations
9.
Liu, Jinming, et al.. (2023). Mesenchymal stem cells‐derived extracellular vesicle‐incorporated H19 attenuates cardiac remodeling in rats with heart failure. The Kaohsiung Journal of Medical Sciences. 40(1). 46–62. 3 indexed citations
10.
Dong, Bowen, Hao Li, Lu Ke, et al.. (2023). Sja-Let-7 Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in a Mouse Model via Col1α2. Biology. 12(12). 1465–1465. 2 indexed citations
11.
Zhao, Hui, Bill Kalionis, Xiaoyi Hu, et al.. (2023). The Impact of Abnormal Lipid Metabolism on the Occurrence Risk of Idiopathic Pulmonary Arterial Hypertension. International Journal of Molecular Sciences. 24(18). 14280–14280. 4 indexed citations
12.
Sun, Yuanyuan, Wenhui Wu, Qin‐Hua Zhao, et al.. (2022). CircGSAP regulates the cell cycle of pulmonary microvascular endothelial cells via the miR-942-5p sponge in pulmonary hypertension. Frontiers in Cell and Developmental Biology. 10. 967708–967708. 7 indexed citations
13.
Wei, Yunpeng, Xiaoyuan Liu, Lu Wang, et al.. (2022). Calcium Sensing Receptor Variants Increase Pulmonary Hypertension Susceptibility. Hypertension. 79(7). 1348–1360. 8 indexed citations
14.
Wang, Lan, Li Shen, Bigyan Pudasaini, et al.. (2021). Survival in severe pulmonary hypertension due to chronic lung disease: influence of in‐hospital platelet distribution width. Pulmonary Circulation. 11(3). 1–7. 2 indexed citations
15.
Zhu, Li, Qiang Hao, Feng Tian, et al.. (2021). Dietary Geranylgeranyl Pyrophosphate Counteracts the Benefits of Statin Therapy in Experimental Pulmonary Hypertension. Circulation. 143(18). 1775–1792. 24 indexed citations
16.
Wu, Wenhui, Ping Yuan, Rong Jiang, et al.. (2021). Liver dysfunction in idiopathic pulmonary arterial hypertension: prevalence, characteristics and prognostic significance, a retrospective cohort study in China. BMJ Open. 11(9). e045165–e045165. 3 indexed citations
17.
Li, Jing, Jing Yang, Lingfei Kong, et al.. (2020). Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians. Asian Pacific Journal of Allergy and Immunology. 40(3). 223–231. 8 indexed citations
18.
Wang, Lan, Yuanzhe Jin, Qin‐Hua Zhao, et al.. (2017). Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension. International Journal of COPD. Volume 12. 3353–3360. 25 indexed citations
19.
Liu, Hui, Jinming Liu, Jian Guo, et al.. (2015). [Correlation between oxygen uptake efficiency and exercise capacity in pulmonary hypertension patients].. PubMed. 95(6). 420–4. 1 indexed citations
20.
Wang, Sujuan, Jinming Liu, Li Ye, et al.. (2010). Evaluation of vaccine potential of phage-displayed Schistosoma japonicum antigens identified with liver extracts of Microtus fortis.. 22(5). 431–436. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alison Campbell Breakdown of academic impact, for papers by Clarence E. Chrisp Breakdown of academic impact, for papers by José Manuel Rodrı́guez-Pérez Breakdown of academic impact, for papers by Ono K Breakdown of academic impact, for papers by Amanda Fisher Breakdown of academic impact, for papers by K. Herkner Breakdown of academic impact, for papers by Frank Stassen Breakdown of academic impact, for papers by Rafael Bojalil Breakdown of academic impact, for papers by Andrew J. Lechner Breakdown of academic impact, for papers by Galileo Escobedo
Rankless by CCL
2026